1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Saad A Khan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer Pembrolizumab - Thyroid Cancer | Phase 2 | Active not recruiting | Saad A Khan | 9 | 2022-02-15 | 2026-09-09 |
| Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Pembrolizumab - Anaplastic Thyroid Cancer | Phase 2 | Completed | Saad A Khan | 6 | 2016-10-01 | 2022-02-10 |
Thyroid Carcinoma, Anaplastic (1) · Thyroid Neoplasms (1)
pembrolizumab (2)
United States (2)
Saad Khan, MD (1)